These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2002552)

  • 1. Phenotypic heterogeneity in a panel of infectious molecular human immunodeficiency virus type 1 clones derived from a single individual.
    Groenink M; Fouchier RA; de Goede RE; de Wolf F; Gruters RA; Cuypers HT; Huisman HG; Tersmette M
    J Virol; 1991 Apr; 65(4):1968-75. PubMed ID: 2002552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture.
    Schuitemaker H; Kootstra NA; de Goede RE; de Wolf F; Miedema F; Tersmette M
    J Virol; 1991 Jan; 65(1):356-63. PubMed ID: 1985204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host range, replicative, and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120.
    Cheng-Mayer C; Shioda T; Levy JA
    J Virol; 1991 Dec; 65(12):6931-41. PubMed ID: 1658383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity.
    de Jong JJ; Goudsmit J; Keulen W; Klaver B; Krone W; Tersmette M; de Ronde A
    J Virol; 1992 Feb; 66(2):757-65. PubMed ID: 1731110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syncytium induction in primary CD4+ T-cell lines from normal donors by human immunodeficiency virus type 1 isolates with non-syncytium-inducing genotype and phenotype in MT-2 cells.
    Todd BJ; Kedar P; Pope JH
    J Virol; 1995 Nov; 69(11):7099-105. PubMed ID: 7474129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression.
    Connor RI; Ho DD
    J Virol; 1994 Jul; 68(7):4400-8. PubMed ID: 7515972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization.
    De Wolf F; Hogervorst E; Goudsmit J; Fenyö EM; Rübsamen-Waigmann H; Holmes H; Galvao-Castro B; Karita E; Wasi C; Sempala SD
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1387-400. PubMed ID: 7888192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insertion of primary syncytium-inducing (SI) and non-SI envelope V3 loops in human immunodeficiency virus type 1 (HIV-1) LAI reduces neutralization sensitivity to autologous, but not heterologous, HIV-1 antibodies.
    Hogervorst E; de Jong J; van Wijk A; Bakker M; Valk M; Nara P; Goudsmit J
    J Virol; 1995 Oct; 69(10):6342-51. PubMed ID: 7666535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates.
    Tersmette M; Gruters RA; de Wolf F; de Goede RE; Lange JM; Schellekens PT; Goudsmit J; Huisman HG; Miedema F
    J Virol; 1989 May; 63(5):2118-25. PubMed ID: 2564898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of two divergent infectious molecular clones of HIV type 1 longitudinally obtained from a seropositive patient by a progressive amplification procedure.
    Chen M; Singh MK; Balachandran R; Gupta P
    AIDS Res Hum Retroviruses; 1997 Jun; 13(9):743-50. PubMed ID: 9171218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variability and function of the long terminal repeat from syncytium-inducing and non-syncytium-inducing human immunodeficiency virus type 1.
    Simm M; Chao W; Pekarskaya O; Sova P; Gupta P; Balachandran R; Volsky DJ
    AIDS Res Hum Retroviruses; 1996 Jun; 12(9):801-9. PubMed ID: 8738432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype.
    Björndal A; Deng H; Jansson M; Fiore JR; Colognesi C; Karlsson A; Albert J; Scarlatti G; Littman DR; Fenyö EM
    J Virol; 1997 Oct; 71(10):7478-87. PubMed ID: 9311827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation.
    Li Y; Hui H; Burgess CJ; Price RW; Sharp PM; Hahn BH; Shaw GM
    J Virol; 1992 Nov; 66(11):6587-600. PubMed ID: 1404605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay.
    Koot M; Vos AH; Keet RP; de Goede RE; Dercksen MW; Terpstra FG; Coutinho RA; Miedema F; Tersmette M
    AIDS; 1992 Jan; 6(1):49-54. PubMed ID: 1543566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and characterization of human immunodeficiency virus type 1 variants diminished in the ability to induce syncytium-independent cytolysis.
    Stevenson M; Haggerty S; Lamonica C; Mann AM; Meier C; Wasiak A
    J Virol; 1990 Aug; 64(8):3792-803. PubMed ID: 1695254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population.
    Cornelissen M; Mulder-Kampinga G; Veenstra J; Zorgdrager F; Kuiken C; Hartman S; Dekker J; van der Hoek L; Sol C; Coutinho R
    J Virol; 1995 Mar; 69(3):1810-8. PubMed ID: 7853521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between genetic and biological properties of biologically cloned HIV type 1 viruses representing subtypes A, B, and D.
    Zhong P; Peeters M; Janssens W; Fransen K; Heyndrickx L; Vanham G; Willems B; Piot P; van der Groen G
    AIDS Res Hum Retroviruses; 1995 Feb; 11(2):239-48. PubMed ID: 7742038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI.
    Peden K; Emerman M; Montagnier L
    Virology; 1991 Dec; 185(2):661-72. PubMed ID: 1683726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotype-associated env gene variation among eight related human immunodeficiency virus type 1 clones: evidence for in vivo recombination and determinants of cytotropism outside the V3 domain.
    Groenink M; Andeweg AC; Fouchier RA; Broersen S; van der Jagt RC; Schuitemaker H; de Goede RE; Bosch ML; Huisman HG; Tersmette M
    J Virol; 1992 Oct; 66(10):6175-80. PubMed ID: 1527855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically and epidemiologically related "non-syncytium-inducing" isolates of HIV-1 display heterogeneous growth patterns in macrophages.
    Aquino-De Jesus MJ; Anders C; Miller G; Sleasman JW; Goodenow MM; Andiman WA
    J Med Virol; 2000 Jun; 61(2):171-80. PubMed ID: 10797371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.